Lentiviral gene therapy with reduced-intensity conditioning for sickle cell disease: a phase 1/2 trial

Michael Grimley, Stella M. Davies, Archana Shrestha, Amy Shova, Monika Asnani, Michael Kent, Farzana Sayani, Charles T. Quinn, Omar Niss, Carolyn Lutzko, Parinda A. Mehta, Pooja Khandelwal, Courtney Little, Sharat Chandra, Sydney Felker, Mengna Chi, Theodosia A. Kalfa, Jennifer Knight‐Madden, Paritha Arumugam, Kristie N. Ramos, Scott R. Witting, Teresa Latham, Frederic D. Bushman, Punam Malik